Subgroup analysis | Study Number | Heterogeneity Test | Effect Model | Incidence(95%CI) | P | |
---|---|---|---|---|---|---|
I2 (%) | P | |||||
Age |  |  |  |  |  | P = 0.0004 |
 < 60 | 83 | P < 0.001 | Random | 5.67% (3.75%− 7.60%) |  | |
 > 60 | 100 | P < 0.001 | Random | 11.48% (8.92%− 14.03%) |  | |
Gender | Â | Â | Â | Random | Â | 0.87 |
Male | 100% | P < 0.001 | Random | 11.80% (9.42%− 14.18%) |  | |
Female | 100% | P < 0.001 | Random | 11.52% (9.19%− 13.86%) |  | |
Study Type |  |  |  |  |  | P < 0.001 |
Case–control | 0 | P = 0.81 | Random | 5.20% (4.20%− 6.21%) |  | |
Cohort study | 100 | P < 0.001 | Random | 12.77% (10.32%− 15.22%) |  | |
Region |  |  |  |  |  | P = 0.004 |
Asia | 83 | P = 0.0006 | Random | 7.70% (4.86%− 10.54%) |  | |
Europe | 100 | P < 0.001 | Random | 13.05% (1.43%− 24.66%) |  | |
North America | 92 | P < 0.001 | Random | 11.62% (11.09%− 12.16%) |  | |
Oceania | 1[26] | - | - | Random | 14.98% (12.34%− 17.62%) |  |
Sample size |  |  |  |  |  | P = 0.57 |
 ≤ 1000 | 89 | P < 0.001 | Random | 12.54% (8.77%− 16.31%) |  | |
1000–10000 | 99 | P < 0.001 | Random | 8.52% (1.92%− 15.12%) |  | |
 > 10,000 | 100 | P < 0.001 | Random | 12.01% (8.52%− 15.50%) |  |